Female and male subjects ?18 years of age with one of the following:
Male or female ? 18 years of age.
Serum creatinine based on age/gender as follows:\r\n* Age 0 month to < 6 months; male 0.4; female 0.4\r\n* Age 6 months to < 1 year; male 0.5; female 0.5\r\n* Age 1 to < 2 years; male 0.6; female 0.6\r\n* Age 2 to < 6 years; male 0.8; female 0.8\r\n* Age 6 to < 10 years; male 1; female 1 \r\n* Age 10 to < 13 years; male: 1.2; female: 1.2\r\n* Age 13 to < 16 years; male: 1.5; female: 1.4\r\n* Age >= 16 years; male: 1.7; female: 1.4
Male and female subjects, age >=18 years (at the time consent is obtained).
Male or female patient, age >18 years
Male or female subjects who are at least 18 to 70 years of age
Male or Female at least 18 years of age
Male or female subjects at least 18 years of age.
Male or female ? 18 years of age at time of consent.
Male or female patients age ? 18 years of age at the time of informed consent
Female or male ? 18 years of age.
Male or female, ?18 years of age (?20 years of age in Taiwan)
Male or female ? 12 years of age
Patient (male or female) ?12 years of age
Male or female patients >/= 18 years of age with relapsed or refractory AML
Male or female patients >/= 65 years of age with previously untreated AML ineligible for receiving standard intensive therapy
Male or female ? 18 years of age
Male or female patient ? 18 years of age
Male or non-pregnant and non-lactating female, and ?18 years of age.
Female or male patients ?18 years-of-age
A serum creatinine (mg/dL) based on age/gender as follows:\r\n* Age: 3 to < 6 years; Male: 0.8; Female: 0.8\r\n* Age: 6 to < 10 years; Male: 1; Female: 1\r\n* Age: 10 to < 13 years; Male: 1.2; Female: 1.2\r\n* Age: 13 to < 16 years; Male:1.5; Female: 1.4\r\n* Age >= 16 years; Male: 1.7; Female: 1.4
Male or female at least 18 years of age.
Male or female patients, ? 18 years of age at the time of obtaining informed consent.
Male or female, ? 18 years of age
Subject is male or female and at least 18 years of age.
Female or male, age ? 18 years.
Male or female patients, ? 18 years of age at the time of obtaining informed consent.
Age >18 year at the time of obtaining informed consent, male or female.
Male or female subjects must be at least 18 years of age.
Male or female patients ?18 years of age.
Male and female patients ? 18 years of age;
Age: Male or female age ? 2 years and < 22 years unless enrolled in Part E
Male or female patients, age ?18 years (?19 years for South Korea)
Male or female patients ? 18 years of age
Patients (male or female) ? 18 years of age.
Male or female patients ?18 years of age
Male > 18 years of age
Male or Female ? 18 years of age
Male or female participants age 2 years to less than18 years and less than or equal to 25 years for osteosarcoma subjects at the time of informed consent.
Male or female ? 18 years of age
Male or female patients ? 18 years of age
Male or female ? 18 years of age
Age ?18 years male or female.
Male or female ? 18 years of age.
Serum creatinine based on age or creatinine clearance or radioisotope glomerular filtration rate (GFR) > 70 ml/min/ml/min/1.73 m^2\r\n* Age 1 to < 2 male 0.6 female 0.6\r\n* Age 2 to < 6 male 0.8 female 0.8\r\n* Age 6 to < 10 male 1 female 1\r\n* Age 10 to < 13 male 1.2 female 1.2\r\n* Age 13 to < 16 male 1.5 female 1.4\r\n* Age > 16 male 1.7 female 1.4
Male or female children, <13 years of age
Male or female patients ? 18 years of age.
Male and female patients must be at least 18 years of age.
Male or female patients, ? 18 years of age at the time of obtaining informed consent.
Be male or female at least 18 years of age (at the time consent is obtained);
Male or non-pregnant, non-lactating female patient at least 18 years of age at the time of consent;
Male or female ?18 years of age
Participant must be male or female at least 18 years of age at time of screening
Male or female age ?18 years old;
Male or female, Age ? 18 years.
Male or female patients ? 18 years of age.
Is a male or female ? 18 years of age, that has provided written informed consent.
Male or female ? 2 years of age;
Age >18 years of age; male or female.
Male or female patient with age ? 18 years
Male or female at least 12 years of age;
Male or female patients, ? 18 years of age at the time of obtaining informed consent.
Female or male subjects ?18 years-of-age.
Male or female, age ? 18 years
Male or female ? 21 years of age at Screening Visit.
Male, age 45 to 80 years
Male or female ?18 years of age
Male or female subjects ? 55 years of age
Male or female ? 18 years of age at time of consent
Male or female ?18 years of age
Male or female patients over 18 years of age
Male or female ? 18 years of age.
Female or male ?18 years of age
Female, age ? 18 years
Male or female ?18 years of age
Subject is male or female and at least 18 years of age.
Male or Female at least 18 years of age
Male or female patients age ? 18 years of age at the time of informed consent
Adult, at least 18 years of age, male or female
Male or female ? 18 years of age
Male or female ? 18 years of age at time of consent.
Male and female subjects; age ? 18
Male subjects of age ? 18 years
Male or Female patients at least 18 years of age
Male patients >/= 18 years of age
Male or female patients >= 18 years of age
male or female patients ? 18 years of age.
Male or female patients > 18 years of age
Male or female at least 18 years of age.
Male ?18 years of age.
Female subjects with age ? 18 years
Male or female, at least 18 years of age at time of screening
Male and female ? 18 years of age.
Male or female patients of at least 18 years of age
Male or female patients ? 18 years of age (only female patients in breast cancer cohort of Phase 2).
male or female greater than or equal to 18 years of age
Male or female 18 years of age or over.
Male participants who are ?18 years of age
Age ? 18 years, male or female subjects.
Subjects (male and female for Part A and female for Part B) will be at least 18 year of age.
Female, ?18 years of age
Male or female ?18 years of age
Male or female, at least 18 years of age
Age ?15 years (US only), and 18-80 (rest of world (ROW)), male or female.
Male or female at least 18 years of age
Male or female patients ? 18 years of age
Male and female patients at least 18 years of age
Male or female patients, >= 18 years of age at the time of obtaining informed consent.
Male or female ?18 years of age
Male or female >=18 years of age.
Male or female ?18 years of age.
Male or female subject ? 18 years of age
Male or female patients, > 18 years of age.
Male or female at least 18 years of age
Patients must be female at least 18 years of age.
Male or female greater than or equal to 18 years of age.
Male and female patients from 1 month to less than 18 years of age.
Male or female ?18 years of age at the time of informed consent
Male or female age ?18 years
Female or male at least 18 years of age.
Female or male of at least 18 years of age.
Male or female, age >=18 years (at the time consent is obtained).
Female, Age ?18 years.
Male or female subjects at least 18 years of age at the time of consent;
Female age 18 to 55 years
Male or female, age ? 18 years and ? 65 years
Male or female subjects ? 18 and ? 75 years of age
Subject must be female ? 40 years of age
Female or male patients at least 18 years of age
Female over 21 years of age;
Male or female, age ? 18 years old at the time of consent.
Male or female subjects who are at least 18 years of age;
Male or female age ? 18 years at the time of informed consent
Male or female, ? 18 years of age.
Subjects (male or female) ? 18 years of age
Male or female subjects 2 to ? 21 years of age at the time of informed consent/assent.
Male or female patients ? 18 years of age